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MATERIALS AND METHODS 
Immunohistochemistry 
To determine the daily rhythm of ORX expression we used adjacent series of sections from 
the same animals used for in situ hybridization. Sections were fixed in phosphate-buffered 4% 
paraformaldehyde, pH 7.4 (Sigma, 4% PFA) for 15 min. Following Phosphate buffered Saline 
(PBS) and 0.05% Tween-20 washing steps, sections were blocked with 10% normal donkey 
serum for 1h diluted in PBS and 0.3% Tween-20 (PBS-T), and then incubated overnight at 
4°C with a goat anti-orexin A antibody diluted in PBS-T and 5% serum (1:5000; Santa Cruz 
Biotechnology, Santa Cruz, CA). For secondary labeling, sections were incubated in 
biotinylated donkey anti-sheep secondary antibody for 2h at room temperature (1:1000; 
Jackson ImmunoResearch, West Grove, PA) diluted in PBS-T. Sections were then washed in 
PBS and incubated in avidin-biotin complex (ABC; Vector Elite kit; Vector Laboratories, 
Burlingame, CA; 1:500 in PBS) for 1h at room temperature. After PBS-T washes, sections 
were incubated in 0.05% 3,3’-diaminobenzidine tetrahydrochloride (DAB; Sigma), nickel 
sulfate 1% (Fisher Scientific, Pittsburgh, PA) and 0.015% hydrogen peroxide dissolved in 
distilled water.  
For double c-Fos/ORX labeling, we used the ABC/nickel-enhanced 3,3′-diaminobenzidine 
tetrahydrochloride (NiDAB) method. Mice were deeply anesthetized with isoflurane and 
transcardialy perfused with 50 ml of saline solution (Sigma, 0.9%), followed by 50 ml of 4% 
PFA. Brains were extracted and postfixed in the same fixative overnight. Frozen sections (30 
μm) were cut across the entire rostro-caudal hypothalamus (interaural 2.58mm to 2.10mm; 
Paxinos & Franklin 2001) and stored at 4°C. Following a blocking step with 10% normal 
2 
 
donkey serum for 1h diluted in PBS-T, sections were incubated in the rabbit anti-c-Fos 
primary antibody (Santa Cruz, Santa Cruz, CA, USA; 1:10,000) overnight at 4°C, and then in 
biotinylated donkey anti-rabbit secondary antibody for 2h at room temperature (1:1000; 
Jackson ImmunoResearch, West Grove, PA). Next, sections were incubated in avidin-biotin 
complex (ABC; Vector Elite kit; Vector Laboratories, Burlingame, CA; 1:500 in PBS) for 1h 
at room temperature. After washing in PBS-T, sections were incubated in 0.05% DAB, 1% 
nickel ammonium sulfate and 0.015% hydrogen peroxide dissolved in distilled water. c-Fos 
staining was followed by labeling for ORX-A. Sections were re-incubated with the blocking 
solution before incubation in the second primary antiserum, goat anti-ORX (1:5000) 
overnight at 4°C. The secondary antibody, biotinylated donkey anti-sheep IgG (1:1000), was 
applied for 2h at room temperature. After, sections were incubated in avidin-biotin complex 
for 1h. Sections were then washed again in PBS and incubated in a 0.05% solution of DAB 
containing 0.03% H2O2 without nickel ammonium sulfate to obtain a brown staining. 
Cell counting procedures 
Cells were visualized using a Leica DMRB microscope (Leica Microsystems, Rueil-
Malmaison, France) equipped with an Olympus DP50 digital camera (Olympus France, 
Rungis, France). Image caption was standardized using fixed lighting parameters on the 
microscope and camera software (Viewfinder Lite, Olympus). Since ORX are present in a 
large part of the LH (medial, lateral perifornical area), for quantification we selected neurons 
in the lateral part of the nucleus (Paxinos & Franklin 2001). For counting the intensity of 
ORX-positive cells, three bilateral images were collected in the region of the whole lateral 
hypothalamus with the highest concentration of positive cells (interaural 2.58-2.10mm; 
Paxinos & Franklin, 2001) using the NIH ImageJ software (Rasband, W.S., US National 
Institutes of Health, Bethesda MD, USA). For each animal, 1 rostral, 1 mid and 1 caudal LH 
sections were photographed and converted to 8-bit grayscale. The region of interest was 
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determined using a circle surrounding the labelled neurons and the integrated density of 
individual neurons was measured and subtracted from a background value taken from 
neighbour tissue with no staining. An average of 10 neurons per LH section was analysed and 
the mean integrated density was determined for each animal. For each time point the labeling 
intensity was calculated as the mean ± SEM.  
For quantitative assessment of c-Fos expression in ORX cells, three sections where ORX 
staining was the highest were selected. Neurons were classified as double labeled according to 
the presence above background of black NiDAB (c-Fos) reaction product in the cell nucleus 
and brown (DAB) ORX in the cytoplasm. For c-Fos colocalization, ORX cells were counted 
for each animal. Total number of c-Fos/ORX double-labeled cells was estimated as the 
percentage of c-Fos/ORX co-labeled cells on the total number of ORX-positive cells. 
Adipose tissue and hormonal determinations 
For adipose tissue determination, total epididymal fat (mass of white adipose tissue) was 
obtained in both WT and KO mice. After decapitation, trunk blood was collected into 2 ml 
Eppendorf heparinised tubes containing 10μl of 4% EDTA. Blood samples were centrifuged 
at 5000 rpm for 10 min, and plasma was stored at -80°C before determination of plasma leptin 
concentration by radioimmunoassay. We used a mouse Leptin ELISA Kit (EZML-82K, 
Millipore, USA). The limit of sensitivity of the leptin assay was 0.05 ng ml−1.  
Molecular analysis of the ORX promoter 
Plasmids for luciferase assay 
Full-length mouse cDNAs encoding, LAC-Z and REV-ERBα were cloned into a pSCT1 
expression vector. REV-ERBα was fused in-frame to 2 N-terminal HA tags. Bmal1 promoter 
was cloned into a pGL2 basic vector (Promega). This construct express the firefly luciferase 
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under control of the Bmal1 promoter. It was used as positive controls for BMAL1/NPAS2 and 
REV-ERBα assays.  
Orexin promoter (ORX) cloning and mutagenesis 
The 1.6 kb region upstream the coding sequence of the orexin gene was subcloned by PCR 
into a pJet vector using a Phusion™ kit (Finnzymes) according to manufacturer’s manual. 
PCR product was ultimately cloned into a pGL2 basic vector (Promega) to allow expression 
of the firefly luciferase under control of the Orx promoter.  
To mutate the RORE site situated 1.6 kb upstream of the coding region of the orexin gene, a 
PCR using the Pfu polymerase was performed directly on the original Ox-pGL2 template with 
48 bases long forward and reverse primers overlapping the RORE sequence. The RORE 
sequence (TGACCT) was replaced by an EcoRV site (GATATC) to allow both mutation of 
the RORE sequence and selection of positive clones. After the PCR, original templates were 
digested using Dpn1. E.coli bacteria were then transformed with the PCR product. All 
positive clones were isolated and digested with EcoRV to check for successful insertion of the 
restriction site. Plasmids were ultimately sequenced to confirm the mutation.  
Luciferase assay 
Proliferating NG108-15 cells cultured in DMEM High Glucose (Sigma-Aldrich) 
supplemented with 10% fetal calf serum and 100 U/mL penicillin/streptomycin (Amimed) 
were transfected with 0.5 µg of either a Bmal1::pGL2 vector (positive controls), a basic pGL2 
(negative control), an Ox::pGL2 or a mutated Ox::pGL2. These plasmids were co-transfected 
with 0.1 µg of a LAC-Z expression vector to control for transfection efficiency, together with 
the indicated amounts of expression vectors using LINPEI Max (Polyplus Transfection) in 6-
wells plates. Cells were harvested 24h after transfection. Cell lysates were then processed to 
perform a luciferase assay. Briefely 100 µl of Luciferase reaction buffer (25 mM Tris-HCl, 1 
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mM ATP, 10 mM MgAc, 0.1 mg/ml BSA) was added to 10 µl of the cell lysates in a 96-wells 
plate. 100 µl of Luciferin injection buffer (20 mg/l Coenzyme A, 30 mg/l Luciferin (Chimie 
Brunschwig), 12.5 mM PIPES) was added directly by a pump inside the luminometer and 
luminescence was measured for 10 sec. In parallel to the luciferase assay, 5 µl of the cell 
lysate was used to perform a 4-methylumbelliferyl β-D-galactopyranoside (MUG) assay. 
Briefely, 140 µl of a MUG solution (1mg/ml MUG in 100 mM Na3PO4 / 2 mM MgCl2 / 
pH=8.0) was added to cell lysates in a 96-wells plate and incubated 5 min at 37°C. The 
reaction was stopped by addition of 100 µl of 300 mM glycine / 15 mM EDTA / pH= 11.5. 
MUG is a fluorogenic substrate of ß-galactosidase and its hydrolysis product has an 
absorption/emission maxima between 360/449 nm that was measured directly in a plate 
reader. Luciferase values were normalized to MUG assay values. Luciferase activity was 
normalized using basic pGL2 as a control. 
Chromatin immunoprecipitation 
C57BL/6J WT mice, between 4 and 7 months of age, were kept in 12 h light-12 h dark 
conditions (LD 12:12; lights on at 8:00 AM) at an ambient temperature of 24.5–25.5°C. They 
were housed 2 to 5 per cage with food and water ad libitum. Mice were sacrificed at ZT-5 and 
ZT-17. Brain tissue (LH or cerebellum, n=3 per structure and time point) was immediately 
homogenized in PBS with 1% formaldehyde. Cross linking was continued for 5 min at room 
temperature. Cross-linking reactions were stopped by the addition of 25 ml of ice-cold 2.2 M 
sucrose in 150 mM glycine, 10 mM HEPES pH 7.6, 15 mM KCl, 2 mM EDTA, 0.15 mM 
spermine, 0.5 mM spermidine, 0.5 mM DTT and 0.5 mM PMSF. The homogenate was 
layered on top of a cushion of 2.05 M sucrose (containing the same ingredients and including 
10% glycerol and 125 mM glycine) and centrifuged for 30 min at 24,000 rpm (100,000g). 
Nuclei were resuspended in 20 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTAand sedimented 
at 1,500g. They were then resuspended in the same buffer supplemented with SDS (final 
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concentration, 1%), and sonicated 10 times for 15 s. The fragmented cross-linked chromatin 
was then diluted with the same buffer containing 1% Triton X-100. About 2x106 genomic 
copies were used as starting material for DNA quantification experiments. 
Coimmunoprecipitated DNA fragments were captured by protein A-agarose beads. Beads 
were collected by centrifugation, washed with lysis buffer supplemented with 1% Triton X-
100 and 150 mM NaCl and cross-links were reversed overnight at 65 °C in 100 µl of 20 mM 
Tris pH 7.5, 0.1% NP-40, 10 µg/ml BSA, 0.1 mM EDTA, 0.02 µg/ µl salmon sperm DNA. 
Four microliters of each reaction were directly used in 20-µl real-time PCR reactions. The 
amount of DNA was quantified against a 2-CT calibration curve prepared from mouse genomic 
DNA. Experiments were performed with 3 independent preparations of mouse brain 
chromatin. Antibodies against REV-ERBα are from a non-commercial batch made for U.A. 
lab. The specificity of the antibody was verified by competition experiments with peptides 
obtained from the same source. 
 
Supplemental figure legends 
Figure S1. (A) Daily rhythm of water drinking behavior in both WT and KO mice. Animals 
drank more water at night than at day and this difference is statistically significant (F3, 27 = 
11.75; p < 0.01). However, no differences were found between genotypes (F1, 9 = 0.66; p = 
0.43). (B) Daily intake (ml) and (C) preference (%) of saccharin at 1% in WT and KO mice. 
Intake and preference were not differences between genotypes (Intake, F1, 9 = 1.49; p < 0.25, 
preference, F1, 9 = 3.21; p = 0.1), although there was a significant daily rhythm of both intake 
and preference (Intake, F3, 27 = 33.17; p < 0.01, Preference, F3, 27 = 4.36; p = 0.01). 
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Figure S2. Representative double plot actograms of locomotor activity of WT (A) and KO 
(B) animals. On day 6 both animals received an i.p. injection the antagonist SB-334877 
(20mg/kg), and 4 days later a vehicle injection. Vertical arrows indicate the time of injections 
(ZT12, lights off). Mean activity counts of WT (C) and KO (D) animals of the first three 
hours of activity onset (from ZT12-ZT15) in bins of 30 min. No differences were found 
between vehicle and the antagonist treated animals in both genotypes (WT, F1, 8 = 1.16; p = 
0.31; KO, F1, 6 = 0.007; p = 0.93). For the percent of activity change (E), in relation to night 
activity, after each treatment no differences where found between vehicle and the antagonist 
injection in both genotypes (F1, 14 = 0.005; p = 0.94). In the same animals we measured chow 
food intake, and no differences were found before vs. after treatments (vehicle vs. SB-
334877) in both WT (F) and KO (G) mice (WT, F1, 8 = 0.29; p = 0.6; KO, F1, 6 = 0.02; p = 
0.87). Open symbols show the individual values for each animal and the closed symbols the 
mean value (±SEM) for each condition (vehicle vs. SB-334877). 


